Home LiteratureArticle Details
PMID: 14684564 Published · ppublish English Journal Article

Dysbiosis in inflammatory bowel disease.

Gut ·Vol. 53 ·No. 1 ·2004-01-00 ·Pages 1-4

Tamboli CP, Neut C, Desreumaux P, Colombel JF

Abstract

Abundant data have incriminated intestinal bacteria in the initiation and amplification stages of inflammatory bowel diseases. However, the precise role of intestinal bacteria remains elusive. One theory has suggested a breakdown in the balance between putative species of "protective" versus "harmful" intestinal bacteria--this concept has been termed "dysbiosis". Arguments in support of this concept are discussed.

MeSH Terms
Animals Bacteria/isolation & purification Disease Models, Animal Humans Inflammatory Bowel Diseases/microbiology,therapy Intestines/microbiology Probiotics/therapeutic use
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Tamboli C P
Division of Gastroenterology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. [email protected]
Neut C
Desreumaux P
Colombel J F
References (61)
61 references, click to expand
  1. Selected bacterial antibodies in Crohn's disease and ulcerative colitis.
    Scand J Gastroenterol. 1983 Mar;18(2):217-23 PMID: 6673050
  2. Mucosal flora in inflammatory bowel disease.
    Gastroenterology. 2002 Jan;122(1):44-54 PMID: 11781279
  3. Microbial factors in inflammatory bowel disease.
    Gastroenterol Clin North Am. 2002 Mar;31(1):41-62 PMID: 12122743
  4. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.
    Gastroenterology. 2003 May;124(5):1202-9 PMID: 12730861
  5. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.
    Gut. 1999 Jun;44(6):812-8 PMID: 10323882
  6. Inflammatory bowel disease.
    N Engl J Med. 2002 Aug 8;347(6):417-29 PMID: 12167685
  7. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
    Gastroenterology. 2000 Aug;119(2):305-9 PMID: 10930365
  8. The faecal flora of patients with Crohn's disease.
    J Hyg (Lond). 1981 Aug;87(1):1-12 PMID: 7019315
  9. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.
    J Exp Med. 1994 Dec 1;180(6):2359-64 PMID: 7964509
  10. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
    J Biol Chem. 2003 Feb 21;278(8):5509-12 PMID: 12514169
  11. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice.
    Gastroenterology. 2001 Mar;120(4):900-13 PMID: 11231944
  12. The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives.
    Scand J Gastroenterol. 1988 Nov;23(9):1125-31 PMID: 3247591
  13. Crohn's disease.
    Lancet. 2002 Jan 5;359(9300):62-9 PMID: 11809204
  14. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.
    Gut. 2004 Jan;53(1):91-8 PMID: 14684582
  15. CpG motifs: the active ingredient in bacterial extracts?
    Nat Med. 2003 Jul;9(7):831-5 PMID: 12835699
  16. The immunological and genetic basis of inflammatory bowel disease.
    Nat Rev Immunol. 2003 Jul;3(7):521-33 PMID: 12876555
  17. The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease?
    Antonie Van Leeuwenhoek. 1983 Jun;49(2):119-24 PMID: 6684413
  18. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis.
    Dis Colon Rectum. 2002 Mar;45(3):384-8 PMID: 12068199
  19. Chicory fructooligosaccharides and the gastrointestinal tract.
    Nutrition. 2000 Jul-Aug;16(7-8):677-9 PMID: 10906595
  20. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique.
    J Med Microbiol. 1991 Oct;35(4):238-43 PMID: 1941994
  21. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease.
    Gastroenterology. 1998 Dec;115(6):1405-13 PMID: 9834268
  22. Exposure to schistosome eggs protects mice from TNBS-induced colitis.
    Am J Physiol Gastrointest Liver Physiol. 2003 Mar;284(3):G385-91 PMID: 12431903
  23. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin.
    J Nutr. 1999 Jul;129(7 Suppl):1438S-41S PMID: 10395616
  24. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli.
    Infect Immun. 1999 Jun;67(6):2969-74 PMID: 10338507
  25. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.
    Appl Environ Microbiol. 1999 Nov;65(11):4799-807 PMID: 10543789
  26. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls.
    Gastroenterology. 1999 Nov;117(5):1089-97 PMID: 10535871
  27. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.
    Gastroenterology. 1999 May;116(5):1107-14 PMID: 10220502
  28. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2.
    J Biol Chem. 2003 Oct 24;278(43):41702-8 PMID: 12871942
  29. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora.
    Infect Immun. 1981 Apr;32(1):225-31 PMID: 7216487
  30. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.
    Gut. 2003 Feb;52(2):237-42 PMID: 12524406
  31. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease.
    Am J Gastroenterol. 2002 Apr;97(4):939-46 PMID: 12003430
  32. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls.
    Scand J Gastroenterol. 2002 Sep;37(9):1034-41 PMID: 12374228
  33. Pouchitis: result of microbial imbalance?
    Gut. 1994 May;35(5):658-64 PMID: 8200561
  34. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells.
    Gastroenterology. 2003 Apr;124(4):993-1000 PMID: 12671896
  35. Intestinal microflora in human and experimental inflammatory bowel disease.
    Curr Opin Gastroenterol. 2001 Jul;17(4):324-30 PMID: 17031178
  36. Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes.
    Gastroenterology. 1996 May;110(5):1429-37 PMID: 8613048
  37. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
    Scand J Gastroenterol Suppl. 2001;(234):29-40 PMID: 11768558
  38. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization.
    Appl Environ Microbiol. 2000 May;66(5):2263-6 PMID: 10788414
  39. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.
    Gastroenterology. 2002 Sep;123(3):689-99 PMID: 12198693
  40. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease.
    Dig Dis Sci. 1997 Apr;42(4):817-22 PMID: 9125655
  41. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice.
    Gastroenterology. 2003 Jul;125(1):162-77 PMID: 12851881
  42. The faecal flora in ulcerative colitis.
    J Med Microbiol. 1975 Nov;8(4):491-501 PMID: 812997
  43. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease.
    Infect Immun. 1999 Sep;67(9):4499-509 PMID: 10456892
  44. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis.
    Gastroenterology. 1993 Mar;104(3):802-9 PMID: 8440437
  45. Comparative study of bacterial groups within the human cecal and fecal microbiota.
    Appl Environ Microbiol. 2001 Oct;67(10):4939-42 PMID: 11571208
  46. Review article: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis.
    Aliment Pharmacol Ther. 1997 Dec;11 Suppl 3:17-22; discussion 22-3 PMID: 9467975
  47. Influence of inflammatory bowel disease on intestinal microflora.
    Gut. 1978 Dec;19(12):1099-104 PMID: 369959
  48. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment.
    Am J Pathol. 1997 Jan;150(1):91-7 PMID: 9006326
  49. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
    Am J Gastroenterol. 1997 Dec;92(12 Suppl):5S-11S PMID: 9395346
  50. Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation.
    J Exp Med. 2001 Jan 1;193(1):25-34 PMID: 11136818
  51. Antibodies to Eubacterium and Peptostreptococcus species and the estimated probability of Crohn's disease.
    J Hyg (Lond). 1981 Aug;87(1):25-33 PMID: 7252136
  52. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death.
    Infect Immun. 2001 Sep;69(9):5529-37 PMID: 11500426
  53. Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects.
    Antonie Van Leeuwenhoek. 1983 Jun;49(2):125-32 PMID: 6614898
  54. Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease.
    Scand J Immunol. 1996 Jul;44(1):71-9 PMID: 8693294
  55. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.
    J Clin Invest. 1996 Aug 15;98(4):945-53 PMID: 8770866
  56. Binding of hydrogen sulfide by bismuth does not prevent dextran sulfate-induced colitis in rats.
    Dig Dis Sci. 2000 Jul;45(7):1439-43 PMID: 10961726
  57. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.
    Infect Immun. 1998 Nov;66(11):5224-31 PMID: 9784526
  58. Nods: a family of cytosolic proteins that regulate the host response to pathogens.
    Curr Opin Microbiol. 2002 Feb;5(1):76-80 PMID: 11834373
  59. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis.
    J Gastroenterol Hepatol. 2000 Jan;15(1):61-8 PMID: 10719749
  60. Alteration of V beta usage and cytokine production of CD4+ TCR beta beta homodimer T cells by elimination of Bacteroides vulgatus prevents colitis in TCR alpha-chain-deficient mice.
    J Immunol. 2000 Nov 15;165(10):5891-9 PMID: 11067950
  61. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody.
    J Gastroenterol Hepatol. 2002 Aug;17(8):849-53 PMID: 12164960
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
DOI
10.1136/gut.53.1.1
Email
[email protected]
Published
2004-01-00
Pages
1-4
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1773911
Subset
IM
Corrections
CommentIn
PMID: 15194668
External Links
PubMed source DOI: 10.1136/gut.53.1.1 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2